Carregant...

Loss of ARID1A Expression Correlates with Stages of Tumor Progression in Uterine Endometrioid Carcinoma

ARID1A is a recently identified tumor suppressor that functions in chromatin remodeling. Inactivating mutations of ARID1A and loss of its expression most frequently occur in ovarian clear cell carcinoma, ovarian endometrioid carcinoma, and uterine endometrioid carcinoma. In this study, we performed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mao, Tsui-Lien, Ardighieri, Laura, Ayhan, Ayse, Kuo, Kuan-Tin, Wu, Chen-Hsuan, Wang, Tian-Li, Shih, Ie-Ming
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787317/
https://ncbi.nlm.nih.gov/pubmed/24076775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0b013e3182889dc3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!